JODY AMAZON: Open Payments
NPI 1427038470 · SNELLVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 49 payments from 11 companies in 2025. Trend: 2023 $522 · 2024 $898 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $267 |
| Otsuka America Pharmaceutical, Inc. | 9 | $203 |
| Eisai Inc. | 2 | $140 |
| ACADIA Pharmaceuticals Inc | 5 | $132 |
| Teva Pharmaceuticals USA, Inc. | 5 | $104 |
| Vanda Pharmaceuticals Inc. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $76 |
| ABBVIE INC. | 3 | $50 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $23 |
Products named: INGREZZA, REXULTI, Leqembi, NUPLAZID, COBENFY, UZEDY, VRAYLAR, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
